SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1103 participants.
Also called NCT04722250
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,103 participants
- Sponsor
- Registry
-
NCT04722250
-
- Other papers using this trial's data
- Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus
- Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Canada, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04722250. Randomized; no masking; primary purpose treatment. Start 2021-04-02 (actual); primary completion 2023-11-10 (actual). Results posted on 2025-03-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
- Acronym
- SMART
- Condition
- Symptomatic Aortic Stenosis
- Condition
- Aortic Valve Stenosis
- Condition
- Aortic Valve Replacement
- Intervention (Device)
- Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems
- Intervention (Device)
- Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct04722250- Content hash
b6aa00dfb41dd52590f347ef2d8fdeaed6710f7888614174b58fa87c2e8c5b14